Tag: Pharmaceuticals
Press Releases
Record international attendance at CPHI & PMEC China 2025 as China in-licensing deals and international partnering increase
China’s biotech sector is now a key driver of innovation across global pipelines, as CPHI Shenzhen prepares for largest ever influx of foreign dealmakers
Sino-international...
Interviews
Conversation with Billy Amzal, Phastar’s new Head of Strategic Consulting
You’ve had a diverse career across biotech, pharma, consulting, and public health. What experiences have shaped your approach to data science and strategic consulting?
I...
Industry Reports
Packaging Market for Temperature-Sensitive Pharmaceuticals
In the complex and unforgiving world of pharmaceutical logistics, every degree matters. The temperature-controlled pharma packaging market happens to stand as a silent guardian of...
BioPharma
America’s AI Action Plan Boosts Pharmaceutical Innovation
Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan
America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel...
BioPharma
Trump To Roll-Out 340B Drugs Discount Program in 2026
The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals...
Press Releases
Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA
Sino Biological US, Inc. proudly unveils ProPure™, an industry-leading line of ultra-pure, endotoxin-free recombinant proteins, fully produced in the USA at its state-of-the-art Center...
BioPharma
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read